Where Life Sciences Data Becomes Business Impact
A unified data and platform architecture for life sciences.
The next level of innovation does not happen in the lab alone. It is driven by a consistent, secure, and scalable data architecture that connects research, production, and business processes.
We design and build the integrated data and platform architecture to go to that next level.
The central transformation questions
Many life sciences organizations still struggle with fragmented data, siloed systems and complex legacy landscapes. As a result, three core challenges must be addressed.
Orchestrating Data Across R&D, Manufacturing & Business
Data across R&D, manufacturing, supply chain, and business must be connected to enable real-time access and reduce time-to-insight.
Scaling AI While Ensuring Compliance
AI initiatives must scale in regulated environments, requiring standardized and governed data as well as architectures that ensure compliance by design.
Modernizing Legacy Systems & Moving to a Platform Strategy
Legacy systems must be modernized without disrupting operations, requiring an integrated data, cloud, and observability strategy.
Strategic fields of action
A unified data foundation enables real-time data flows, standardized information architectures and end-to-end observability across platforms. This creates the foundation for scalable AI and governance by design in regulated environments.
Unified data & observability
AI can only scale when research and lab data are harmonized and integrated across the entire lifecycle. Scalable AI and ML platforms enable faster insights and secure global collaboration.
AI-driven acceleration of R&D
Connecting MES, production, and enterprise systems enables real-time integration between plant and enterprise platforms. Zero-trust architectures and cloud strategies ensure security and scalability in regulated production environments.
IT/OT & manufacturing integration
Event-driven process architectures create transparency across procurement, supply chain, finance, and operations. This enables real-time performance monitoring and better decision-making across the organization.
End-to-end business visibility
Why Mimacom
Our goal is to make digital infrastructure a true enabler of innovation in life sciences. Mimacom modernizes IT landscapes and builds integrated data and platform architectures for regulated environments.
Life Sciences Expertise & Technology Competence
Mimacom focuses on the human factor in life sciences. With deep market expertise and the right technology, we develop custom software solutions for hospitals, pharmaceutical organizations, and laboratories.
Platform & Architecture Expertise
Mimacom supports organizations in building modern cloud-native data platforms, implementing event-driven architectures, and establishing enterprise observability strategies.
Modernization Without Operational Risk
Complex IT landscapes can be modernized without operational risk while ensuring regulatory-compliant cloud and data governance models.
Trusted by
Next Steps
We propose a focused exchange on:
- The maturity level of your current data and platform architecture
- Integration potential between pharma & diagnostics
- Scaling AI initiatives
- Modernization of legacy structures
The goal is to identify concrete, quick wins with measurable impact.
Discover what's new at Mimacom
How Mimacom and Takeda Partnered to Develop Life-Changing Digital Medical Applications
Founded in 1781, Takeda Pharmaceuticals has expanded from its Japanese roots and has grown into a global industry leader. In 2019, Takeda acquired the...
Turning Material Compliance From a Legal Requirement into a Strategic Advantage
Key Takeaways Regulatory complexity for manufacturing companies is growing faster than most IT lands...
How Top Enterprises Future-Proof Their Tech Stack with AI
Is your IT infrastructure ready for AI? From scaling bottlenecks to legacy roadblocks, enterprise sy...
Why 70% of Digital Transformations Still Fail – And What Mimacom Is Doing Differently
“Seventy percent of transformations fail.” This statistic from McKinsey & Co. has been repeated for ...